1-2 of 2
Cyrille Hullin
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

VELCADE/Dexamethasone (Vel/D) Versus VAD as Induction Treatment Prior to Autologous Stem Cell Transplantion (ASCT) in Newly Diagnosed Multiple Myeloma (MM): Updated Results of the IFM 2005/01 Trial.

Jean Luc Harousseau, MD, Claire Mathiot, MD, Michel Attal, MD, Gerald Marit, MD, Denis Caillot, MD, Mohamad M.M. Mohty, MD, Cyrille Hullin, MD, Thierry T.F. Facon, MD, Iain I.W. Webb, MD, Philippe Moreau, MD
Journal: Blood
Blood (2007) 110 (11): 450.
https://doi.org/10.1182/blood.V110.11.450.450
Published: 2007
Journal Articles

Tandem autologous stem cell transplantation in high-risk de novo multiple myeloma: final results of the prospective and randomized IFM 99-04 protocol

Clinical Trials & Observations
Philippe Moreau, Cyrille Hullin, Frédéric Garban, Ibrahim Yakoub-Agha, Lotfi Benboubker, Michel Attal, Gérald Marit, Jean-Gabriel Fuzibet, Chantal Doyen, Laurent Voillat, Christian Berthou, Nicolas Ketterer, Philippe Casassus, Mathieu Monconduit, Mauricette Michallet, Albert Najman, Jean-Jacques Sotto, Régis Bataille, Jean-Luc Harousseau, for the Intergroupe Francophone du Myélome group
Journal: Blood
Blood (2006) 107 (1): 397–403.
https://doi.org/10.1182/blood-2005-06-2573
Published: 2006